Global Anatomic Pathology Market to expand at 6.1% CAGR through 2026

May 06, 2020


As per the report titled ‘Global Anatomic Pathology Market Size study, by Product & Service (Services, Consumables, Instruments) By Application (Disease Diagnostics, Medical Research) By End User (Hospital Laboratories, Clinical Laboratories, Other End Users) and Regional Forecasts 2019-2026’, available with  Market Study Report LLC, global anatomic pathology market was worth USD 31.10 billion in 2018 and is estimated to grow with a CAGR of 6.10% during 2019-2026.
 

Anatomic pathology is a medical field that analyzes diseases based on biochemical, microscopic, macroscopic, immunologic, and molecular inspection of body organs and tissues. The key role of anatomic pathology is the identification of the abnormalities that can aid in diagnosing disease and managing treatment. 
 

Escalating cases of cancer and other target diseases coupled with growing preference for personalized medicines are the primary growth drivers of global anatomic pathology market. According to Cancer Research UK, there were approximately 17 million new cancer cases across the globe in 2018 and the number is estimated to climb to 27.5 million new cases by 2040. Rising prevalence of diseases like cancer and favorable reimbursement scenario in emerging economies will foster the market growth in the coming years. However, dearth of a skilled professionals may hinder the industry growth during the forecast period.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2456356/
 

Considering the regional outlook, worldwide anatomic pathology industry is divided into North America, Europe, Asia Pacific, Latin America and Rest of the World, wherein North America is slated to account for a significant market share over study timeline. Easy accessibility of advanced technologies, promptness and affordability of healthcare services along with well-established healthcare infrastructure are supporting the regional business outlook.
 

Meanwhile, Asia-Pacific anatomic pathology market is slated to exhibit strong CAGR during 2019-2026, owing to rising prevalence of chronic diseases and other targeted diseases in the region.
 

Major players in global anatomic pathology market are Danaher corporation, F. Hoffman-La Roche Ltd., Thermo Fisher Scientific, Hologic Inc., BioGenex Laboratories, Agilent Technologies, Sakura Finetek USA Inc., Becton Dickinson & Company, Bio SB, and Merck KGaA.